Jauch KW - Search Results

1

Vascular targeting in pancreatic cancer: the novel tubulin-binding agent ZD6126 reveals antitumor activity in primary and metastatic tumor models.

Kleespies A, Köhl G, Friedrich M, Ryan AJ, Barge A, Jauch KW, Bruns CJ. Kleespies A, et al. Among authors: jauch kw. Neoplasia. 2005 Oct;7(10):957-66. doi: 10.1593/neo.05304. Neoplasia. 2005. PMID: 16242078 Free PMC article.

2

Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?

Kleespies A, Jauch KW, Bruns CJ. Kleespies A, et al. Among authors: jauch kw. Drug Resist Updat. 2006 Feb-Apr;9(1-2):1-18. doi: 10.1016/j.drup.2006.02.002. Epub 2006 Apr 18. Drug Resist Updat. 2006. PMID: 16621676 Review.

3

Antiangiogenic and antitumor activity of a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor ZD6474 in a metastatic human pancreatic tumor model.

Conrad C, Ischenko I, Köhl G, Wiegand U, Guba M, Yezhelyev M, Ryan AJ, Barge A, Geissler EK, Wedge SR, Jauch KW, Bruns CJ. Conrad C, et al. Among authors: jauch kw. Anticancer Drugs. 2007 Jun;18(5):569-79. doi: 10.1097/CAD.0b013e3280147d13. Anticancer Drugs. 2007. PMID: 17414626

4

Matuzumab short-term therapy in experimental pancreatic cancer: prolonged antitumor activity in combination with gemcitabine.

Kleespies A, Ischenko I, Eichhorn ME, Seeliger H, Amendt C, Mantell O, Jauch KW, Bruns CJ. Kleespies A, et al. Among authors: jauch kw. Clin Cancer Res. 2008 Sep 1;14(17):5426-36. doi: 10.1158/1078-0432.CCR-07-5245. Clin Cancer Res. 2008. PMID: 18765534

5

Vascular endothelial growth factor in colorectal cancer.

Guba M, Seeliger H, Kleespies A, Jauch KW, Bruns C. Guba M, et al. Among authors: jauch kw. Int J Colorectal Dis. 2004 Nov;19(6):510-7. doi: 10.1007/s00384-003-0576-y. Epub 2004 Mar 4. Int J Colorectal Dis. 2004. PMID: 14999511 Review.

6

Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer.

Bruns CJ, Koehl GE, Guba M, Yezhelyev M, Steinbauer M, Seeliger H, Schwend A, Hoehn A, Jauch KW, Geissler EK. Bruns CJ, et al. Among authors: jauch kw. Clin Cancer Res. 2004 Mar 15;10(6):2109-19. doi: 10.1158/1078-0432.ccr-03-0502. Clin Cancer Res. 2004. PMID: 15041732

7

Vascular endothelial growth factor in esophageal cancer.

Kleespies A, Guba M, Jauch KW, Bruns CJ. Kleespies A, et al. Among authors: jauch kw. J Surg Oncol. 2004 Aug 1;87(2):95-104. doi: 10.1002/jso.20070. J Surg Oncol. 2004. PMID: 15282704 Review.

8

Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice.

Yezhelyev MV, Koehl G, Guba M, Brabletz T, Jauch KW, Ryan A, Barge A, Green T, Fennell M, Bruns CJ. Yezhelyev MV, et al. Among authors: jauch kw. Clin Cancer Res. 2004 Dec 1;10(23):8028-36. doi: 10.1158/1078-0432.CCR-04-0621. Clin Cancer Res. 2004. PMID: 15585638

9

Clinical significance of VEGF-A, -C and -D expression in esophageal malignancies.

Kleespies A, Bruns CJ, Jauch KW. Kleespies A, et al. Among authors: jauch kw. Onkologie. 2005 May;28(5):281-8. doi: 10.1159/000085198. Epub 2005 Apr 29. Onkologie. 2005. PMID: 15867486 Free article.

10

Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.

Ischenko I, Guba M, Yezhelyev M, Papyan A, Schmid G, Green T, Fennell M, Jauch KW, Bruns CJ. Ischenko I, et al. Among authors: jauch kw. Angiogenesis. 2007;10(3):167-82. doi: 10.1007/s10456-007-9071-3. Epub 2007 May 8. Angiogenesis. 2007. PMID: 17486419

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

606 results

Search Page

Filters